GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgenic Group Inc (TSE:2342) » Definitions » Other Income (Expense)

Transgenic Group (TSE:2342) Other Income (Expense) : 円1 Mil (TTM As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Transgenic Group Other Income (Expense)?

Transgenic Group's other income expense for the Transgenic Group's pretax income for the three months ended in Sep. 2024 was 円0 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2024 was 円1 Mil.


Transgenic Group Other Income (Expense) Historical Data

The historical data trend for Transgenic Group's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgenic Group Other Income (Expense) Chart

Transgenic Group Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -395.59 -171.86 952.16 -278.55 1.02

Transgenic Group Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.16 -2.35 -39.08 10.29 -

Transgenic Group Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Transgenic Group  (TSE:2342) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Transgenic Group Business Description

Traded in Other Exchanges
N/A
Address
1-7-1 Yurakucho, Yurakucho Denki Building South Wing 4th Floor, Chiyoda-ku, Kobe-shi, JPN, 100-0006
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals.

Transgenic Group Headlines

No Headlines